0001209191-23-057799.txt : 20231207
0001209191-23-057799.hdr.sgml : 20231207
20231207183010
ACCESSION NUMBER: 0001209191-23-057799
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231205
FILED AS OF DATE: 20231207
DATE AS OF CHANGE: 20231207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lamond David
CENTRAL INDEX KEY: 0001770790
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38890
FILM NUMBER: 231473608
MAIL ADDRESS:
STREET 1: C/O CORTEXYME, INC.
STREET 2: 269 EAST GRAND AVE.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Quince Therapeutics, Inc.
CENTRAL INDEX KEY: 0001662774
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 901024039
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 611 GATEWAY BLVD., SUITE 273
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-910-5717
MAIL ADDRESS:
STREET 1: 611 GATEWAY BLVD., SUITE 273
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: Cortexyme, Inc.
DATE OF NAME CHANGE: 20160104
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-12-05
0
0001662774
Quince Therapeutics, Inc.
QNCX
0001770790
Lamond David
C/O QUINCE THERAPEUTICS, INC.
611 GATEWAY BLVD., SUITE 273
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
0
Common Stock
2023-12-05
4
P
0
19123
1.01
A
2241418
I
By Blue Devil Trust dated 12/03/2010
Common Stock
2023-12-06
4
P
0
19123
1.02
A
2260541
I
By Blue Devil Trust dated 12/03/2010
Common Stock
2023-12-07
4
P
0
19123
1.01
A
2279664
I
By Blue Devil Trust dated 12/03/2010
Common Stock
301829
D
Common Stock
1734722
I
By David A. Lamond Trust dated 2006
Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the "Trust") and holds sole voting and dispositive power with respect to the shares held of record by the Trust.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.99 to $1.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range.
Mr. Lamond is the trustee of David A. Lamond Trust dated 2006 (the "2006 Trust") and holds sole voting and dispositive power with respect to the shares held of record by the 2006 Trust.
/s/ Brendan Hannah, Attorney-in-Fact for David Lamond
2023-12-07